Holbæk, Denmark, August 15, 2016
As a step towards the commercialisation of the novel DMSO-free cryoprotectant Pentaisomaltose® the website www.pentaisomaltose.com has been launched. Pharmacosmos is actively seeking clients, distributors and partners to join in the establishment of Pentaisomaltose® as the new golden standard for cryopreservation of selected cell types for clinical use.
Pharmacosmos is the only dextran manufacturer holding certificates from the US FDA and European Directorate for the Quality of Medicines (EDQM)
Pharmacosmos delivers a unique dextran quality through a production technology that completely avoids the use of organic solvents and a quality system that meets the strictest cGMP standards for human medicines
Pharmacosmos sells and ships directly to clients everywhere in the World. We deliver Pharmaceutical Quality Dextran of the highest standards, including those of the European Pharmacopoeia (EP), the United States Pharmacopoeia (USP), and the Japanese Pharmacopoeia (JP).
©2020 PHARMACOSMOS A/S
This website contains information on products which is targeted to a wide range of audiences outside US and may contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Monofer®, CosmoFer® and Uniferon® are a registered trademarks of Pharmacosmos A/S. All rights reserved.